The study was conducted in partnership with Abera Bioscience, a platform and vaccine developer with over 30 years of research in the medical, molecular and microbiological fields. Both formulations tested induced strong systemic antibody response in serum (IgG) as well as locally in the...
Read More Details
Finally We wish PressBee provided you with enough information of ( Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology )
Also on site :
- Bosses want you to know AI is coming for your job
- Nigeria: UK Reaffirms Duty-Free Access for 99 Percent of Nigerian Exports Under Trade Scheme
- CDO Cui Li van ZTE op MWC25 Shanghai: Digitale en intelligente evolutie, een nieuw tijdperk van AI-beschaving wordt ingeluid